questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Toxoïdes
Anatoxine staphylococcique
Anatoxine staphylococcique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections à Staphylococcus
Diagnostic microbiologique
Anticorps
Tests sérologiques
Symptômes
Infections à Staphylococcus
Staphylococcus
Identification des espèces
Anatoxines
Réponse immunitaire
Symptômes
5
Intoxication alimentaire
Symptômes
Infections cutanées
Furoncles
Variabilité des symptômes
Staphylococcus
Réactions allergiques
Anatoxines
Prévention
5
Prévention des infections
Hygiène
Infections nosocomiales
Contrôle des infections
Vaccination
Personnes à risque
Transmission des infections
Hygiène personnelle
Traitements
5
Antibiotiques
Infections à Staphylococcus
Toxoïdes
Prévention des infections
Réactions allergiques
Antihistaminiques
Soins des plaies
Infections cutanées
Antibiotiques
Infections à Staphylococcus
Complications
5
Effets secondaires
Réactions allergiques
Septicémie
Défaillance organique
Gestion des complications
Antibiotiques
Infections chroniques
Traitement prolongé
Facteurs de risque
5
Facteurs de risque
Système immunitaire
Diabète
Infections à Staphylococcus
Athlètes
Infections cutanées
Hygiène
Infections communautaires
Personnes âgées
Système immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Anatoxine staphylococcique : Questions médicales les plus fréquentes",
"headline": "Anatoxine staphylococcique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Anatoxine staphylococcique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Anatoxine staphylococcique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Toxoïdes",
"url": "https://questionsmedicales.fr/mesh/D014121",
"about": {
"@type": "MedicalCondition",
"name": "Toxoïdes",
"code": {
"@type": "MedicalCode",
"code": "D014121",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.691"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Anatoxine staphylococcique",
"alternateName": "Staphylococcal Toxoid",
"code": {
"@type": "MedicalCode",
"code": "D013208",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fiona P Havers",
"url": "https://questionsmedicales.fr/author/Fiona%20P%20Havers",
"affiliation": {
"@type": "Organization",
"name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: fhavers@cdc.gov."
}
},
{
"@type": "Person",
"name": "Susan Hariri",
"url": "https://questionsmedicales.fr/author/Susan%20Hariri",
"affiliation": {
"@type": "Organization",
"name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States."
}
},
{
"@type": "Person",
"name": "Nasamon Wanlapakorn",
"url": "https://questionsmedicales.fr/author/Nasamon%20Wanlapakorn",
"affiliation": {
"@type": "Organization",
"name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
}
},
{
"@type": "Person",
"name": "Donchida Srimuan",
"url": "https://questionsmedicales.fr/author/Donchida%20Srimuan",
"affiliation": {
"@type": "Organization",
"name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
}
},
{
"@type": "Person",
"name": "Thaksaporn Thatsanathorn",
"url": "https://questionsmedicales.fr/author/Thaksaporn%20Thatsanathorn",
"affiliation": {
"@type": "Organization",
"name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "No Association of Multiple Sclerosis with",
"datePublished": "2023-07-09",
"url": "https://questionsmedicales.fr/article/37511014",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411254"
}
},
{
"@type": "ScholarlyArticle",
"name": "Alemtuzumab for multiple sclerosis.",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37272540",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD011203.pub3"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Multiple sclerosis treatments].",
"datePublished": "2023-03-23",
"url": "https://questionsmedicales.fr/article/37037639",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.soin.2023.02.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Concurrent diagnoses of Tuberous sclerosis and multiple sclerosis.",
"datePublished": "2023-02-18",
"url": "https://questionsmedicales.fr/article/36863086",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.msard.2023.104586"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society.",
"datePublished": "2022-11-01",
"url": "https://questionsmedicales.fr/article/36317497",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/13524585221129472"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Toxoïdes",
"item": "https://questionsmedicales.fr/mesh/D014121"
},
{
"@type": "ListItem",
"position": 6,
"name": "Anatoxine staphylococcique",
"item": "https://questionsmedicales.fr/mesh/D013208"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Anatoxine staphylococcique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Anatoxine staphylococcique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Anatoxine staphylococcique",
"description": "Comment diagnostiquer une infection staphylococcique ?\nQuels tests sont utilisés pour détecter l'anatoxine ?\nQuels symptômes indiquent une infection staphylococcique ?\nComment différencier les types de staphylocoques ?\nQuel rôle joue l'anatoxine dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Multiple+Sclerosis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Anatoxine staphylococcique",
"description": "Quels sont les symptômes d'une intoxication par anatoxine ?\nComment se manifestent les infections cutanées staphylococciques ?\nQuels signes indiquent une infection systémique ?\nLes symptômes varient-ils selon le type de staphylocoque ?\nQuels symptômes sont associés à l'anatoxine staphylococcique ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Multiple+Sclerosis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Anatoxine staphylococcique",
"description": "Comment prévenir les infections staphylococciques ?\nL'anatoxine staphylococcique est-elle vaccinante ?\nQuelles mesures de prévention en milieu hospitalier ?\nLes personnes à risque doivent-elles se faire vacciner ?\nComment éviter la transmission en milieu communautaire ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Multiple+Sclerosis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Anatoxine staphylococcique",
"description": "Quel traitement est recommandé pour une infection staphylococcique ?\nL'anatoxine staphylococcique est-elle un traitement ?\nComment traiter une réaction à l'anatoxine ?\nQuels soins sont nécessaires pour les infections cutanées ?\nQuand utiliser des antibiotiques pour les infections staphylococciques ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Multiple+Sclerosis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Anatoxine staphylococcique",
"description": "Quelles complications peuvent survenir avec une infection staphylococcique ?\nL'anatoxine peut-elle provoquer des effets secondaires ?\nQuels sont les risques d'une septicémie staphylococcique ?\nComment gérer les complications d'une infection ?\nLes infections staphylococciques peuvent-elles être chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Multiple+Sclerosis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Anatoxine staphylococcique",
"description": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?\nLes personnes diabétiques sont-elles plus à risque ?\nLes athlètes sont-ils à risque d'infections cutanées ?\nComment l'hygiène influence-t-elle le risque d'infection ?\nLes personnes âgées sont-elles plus vulnérables ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Multiple+Sclerosis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection staphylococcique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter l'anatoxine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques peuvent être utilisés pour détecter des anticorps contre l'anatoxine."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection staphylococcique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent rougeurs, gonflements, douleurs et parfois fièvre."
}
},
{
"@type": "Question",
"name": "Comment différencier les types de staphylocoques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses génétiques aident à identifier les espèces."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'anatoxine dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anatoxine est utilisée pour évaluer la réponse immunitaire aux infections staphylococciques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication par anatoxine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des nausées, vomissements et diarrhées."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les infections cutanées staphylococciques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles se manifestent par des furoncles, des abcès et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection systémique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, frissons, et signes de septicémie peuvent indiquer une infection systémique."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de staphylocoque ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la souche et le site d'infection."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à l'anatoxine staphylococcique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des réactions allergiques et des douleurs au site d'injection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections staphylococciques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et désinfecter les blessures aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "L'anatoxine staphylococcique est-elle vaccinante ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour immuniser contre certaines infections staphylococciques."
}
},
{
"@type": "Question",
"name": "Quelles mesures de prévention en milieu hospitalier ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protocoles stricts d'hygiène et de désinfection sont essentiels en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles se faire vacciner ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes à risque d'infections staphylococciques devraient envisager la vaccination."
}
},
{
"@type": "Question",
"name": "Comment éviter la transmission en milieu communautaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le partage d'objets personnels et maintenir une bonne hygiène personnelle."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour une infection staphylococcique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont souvent prescrits, selon la sensibilité de la souche."
}
},
{
"@type": "Question",
"name": "L'anatoxine staphylococcique est-elle un traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, c'est un toxoïde utilisé pour la prévention, pas pour le traitement."
}
},
{
"@type": "Question",
"name": "Comment traiter une réaction à l'anatoxine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent nécessiter des antihistaminiques ou des corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires pour les infections cutanées ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un drainage des abcès et des soins locaux sont souvent nécessaires."
}
},
{
"@type": "Question",
"name": "Quand utiliser des antibiotiques pour les infections staphylococciques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont utilisés lorsque l'infection est confirmée et nécessite un traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une infection staphylococcique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections profondes, des septicémies et des chocs toxiques."
}
},
{
"@type": "Question",
"name": "L'anatoxine peut-elle provoquer des effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des douleurs au site d'injection et des réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une septicémie staphylococcique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La septicémie peut entraîner des défaillances organiques et un risque accru de mortalité."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une infection ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prise en charge rapide avec des antibiotiques et des soins intensifs est cruciale."
}
},
{
"@type": "Question",
"name": "Les infections staphylococciques peuvent-elles être chroniques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent devenir chroniques et nécessiter un traitement prolongé."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent un système immunitaire affaibli, des interventions chirurgicales et des blessures."
}
},
{
"@type": "Question",
"name": "Les personnes diabétiques sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète augmente le risque d'infections staphylococciques en raison de la circulation sanguine altérée."
}
},
{
"@type": "Question",
"name": "Les athlètes sont-ils à risque d'infections cutanées ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les athlètes peuvent être à risque en raison de blessures et de contacts fréquents."
}
},
{
"@type": "Question",
"name": "Comment l'hygiène influence-t-elle le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise hygiène augmente le risque d'infections staphylococciques, surtout dans les milieux communautaires."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: fhavers@cdc.gov.
Publications dans "Anatoxine staphylococcique" :
3 publications dans cette catégorie
Affiliations :
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Science, University of Tennessee, Knoxville, TN, United States.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Science, University of Tennessee, Knoxville, TN, United States.
East Tennessee AgResearch and Education Center-Little River Animal and Environmental Unit, University of Tennessee, Walland, TN, United States.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
NYU School of Medicine, Skirball Institute of Biomolecular Medicine and Departments of Medicine and Microbiology, New York, NY 10016.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, Beijing 100080, China.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 100050, China.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, San Jose 95134, USA.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China. Electronic address: xluo@ipe.ac.cn.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 100050, China. Electronic address: maxiao421@sina.cn.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, Beijing 100080, China.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, Beijing 100080, China.
Publications dans "Anatoxine staphylococcique" :
Multiple Sclerosis (MS) is a common immune-mediated disorder of the central nervous system that affects young adults and is characterized by demyelination and neurodegeneration. Recent studies have as...
Multiple sclerosis (MS) is an autoimmune, T-cell-dependent, inflammatory, demyelinating disease of the central nervous system, with an unpredictable course. Current MS therapies focus on treating and ...
To evaluate the benefits and harms of alemtuzumab alone or associated with other treatments in people with any form of MS....
We used standard, extensive Cochrane search methods. The latest search date was 21 June 2022....
We included randomized controlled trials (RCTs) in adults with any subtype of MS comparing alemtuzumab alone or associated with other medications versus placebo; another active drug; or alemtuzumab in...
We used standard Cochrane methods. Our co-primary outcomes were 1. relapse-free survival, 2. sustained disease progression, and 3. number of participants experiencing at least one adverse event. Our s...
We included three RCTs (1713 participants) comparing intravenous alemtuzumab versus subcutaneous interferon beta-1a for relapsing-remitting MS. Participants were treatment-naive (two studies) or had e...
Compared with interferon beta-1a, alemtuzumab may improve relapse-free survival and sustained disease progression-free survival, and make little to no difference on the proportion of participants with...
The last thirty years have led to the introduction of treatments that reduce the frequency of relapses and slow the progression of multiple sclerosis. They must be prescribed early, chosen according t...
Tuberous sclerosis (TS) is a monogenic disorder which causes disabling neurological symptoms. Similarly, multiple sclerosis (MS) may result in disability, but in contrast, is diagnosed without genetic...
The objective of this study was to develop evidence-based recommendations on pregnancy management for persons with multiple sclerosis (MS)....
MS typically affects young women in their childbearing years. Increasing evidence is available to inform questions raised by MS patients and health professionals about pregnancy issues....
The French Group for Recommendations in Multiple Sclerosis (France4MS) reviewed PubMed and university databases (January 1975 through June 2021). The RAND/UCLA appropriateness method was developed to ...
A strong agreement was reached for all 104 proposed recommendations. They cover diverse topics, such as pregnancy planning, follow-up during pregnancy and postpartum, delivery routes, locoregional ana...
The 2022 recommendations of the French MS society should be helpful to harmonise counselling and treatment practice for pregnancy in persons with MS, allowing for better and individualised choices....
The factor that is most relevant and strongly associated with the clinical course of multiple sclerosis is chronological age. Very young patients exclusively have relapsing remitting disease, whereas ...
Changes in the immune system associated with ageing are known as immunosenescence. This is characterised by a decline in immune response, chronic inflammation and an increased risk of autoimmune disea...
Multiple sclerosis is a chronic inflammatory disease of the central nervous system, caused by an autoimmune reaction. Treatment options have largely increased over the years. In this article, we prese...
The current diagnostic criteria for pediatric onset multiple sclerosis (POMS) are summarized, as well as the evidence for performance of the most recent iteration of McDonald criteria in the pediatric...
There is increasing need for evidence-based data on reproduction for women with multiple sclerosis (MS). First-trimester (first 13 weeks) miscarriages are relatively common in the general population. ...
The Canadian Multiple Sclerosis Pregnancy Study (CANPREG-MS) is a prospective study on women with MS who are pregnant or actively trying to conceive. As far as we are aware, this is the first study on...
There were 208 pregnancies during the study and 36 resulted in first-trimester miscarriage for a rate of 17.31%, within the expected range of 15%-20% for the general population....
CANPREG-MS provides real world data that there does not appear to be an increase in first-trimester miscarriages for women with MS. This information will be helpful to women with MS and their healthca...